drugset / Trial / NCT00259636

Zonisamide for Fibromyalgia & Migraine

NCT00259636

RandomizedParallel-groupDouble-blindTreatment

Summary

Patients with fibromyalgia \& migraine are randomized to receive zonisamide or placebo.

Timeline

Start
2004-08
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Zonisamide Other / unclassified 100 mg
Subject Zonisamide Other / unclassified 300 mg